Work

Abstract P3-08-17: TBCRC 058: A Randomized Phase II Study of Enzalutamide, Enzalutamide with Mifepristone, & Treatment of Physician’s Choice in Patients with Androgen Receptor-Positive Metastatic Triple-Negative or Estrogen Receptor-Low Breast Cancer (NCT06099769)

Year: 2025

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs24-p3-08-17

Authors: Rita Nanda, Yuan Chen, Katia Khoury, Hope S. Rugo, Erica L. Mayer, Lisa A. Carey, Michelle Melisko, Angemael Syldor, Chaya Friedman, Jennifer Savoie, Fresia Pareja, Britta Weigelt, Sarat Chandarlapaty, Nicholas Turner, Joshua Lang, Marina Sharifi, Suzanne Conzen, Tiffany Traina

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411286349

Cites:

Cited by:

Related to: 10